Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mwangana Mubita is active.

Publication


Featured researches published by Mwangana Mubita.


Expert Review of Pharmacoeconomics & Outcomes Research | 2015

Outcome of the first Medicines Utilization Research in Africa group meeting to promote sustainable and rational medicine use in Africa

Amos Massele; Johanita Burger; Norah L. Katende-Kyenda; Francis Kalemeera; Thatoyaone Kenaope; Dan Kibuule; Ogochukwu Mbachu; Mwangana Mubita; Margaret Oluka; Adedunni Olusanya; Bene D Anand Paramadhas; Paulina van Zyl; Brian Godman

The first Medicines Utilization Research in Africa group workshop and symposium brought researchers together from across Africa to improve their knowledge on drug utilization methodologies as well as exchange ideas. As a result, progress was made on drug utilization research and formulating future strategies to enhance the rational use of medicines in Africa. Anti-infectives were the principal theme for the 1-day symposium following the workshops. This included presentations on the inappropriate use of antibiotics as well as ways to address this. Concerns with adverse drug reactions and adherence to anti-retroviral medicines were also discussed, with poor adherence remaining a challenge. There were also concerns with the underutilization of generics. These discussions resulted in a number of agreed activities before the next conference in 2016.


Expert Review of Anti-infective Therapy | 2017

Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications

S. Nakwatumbah; Dan Kibuule; Brian Godman; V. Haakuria; Francis Kalemeera; Amanj Baker; Mwangana Mubita

ABSTRACT Background: Sub-optimal antibiotic prescribing remains a public health concern in Namibia. The objective was to determine the level and predictors of compliance to guidelines in the prescribing of antibiotics in acute infections at a national referral hospital in Namibia to improve future prescribing. Methods: An analytical cross-sectional survey design. The clinical records of patients receiving care were reviewed. Prescribing practices were assessed using a self- administered questionnaire with reference to Namibia Standard Treatment Guidelines (NSTG). Results: The majority of prescriptions (62%) complied with the NSTGs; however, lower than national targets (95%). Most prescriptions were empiric and prescribers typically made reference to the NSTG (58%). Diagnosed infections were principally respiratory infections (58%) and penicillins were the most used antibiotics. Good concurrence between signs and symptoms with the diagnosis indicated on the prescription - OR=5.2 (95% CI: 1.4, 19.2), a diagnosis of upper respiratory tract (p=0.001), oral-dental OR=0.1(95% CI: 0.03,0.3) and urogenital infections OR=0.3(95% CI: 0.1,0.95) and the prescribing of penicillins (p=0.001) or combination antibiotics and amphenicols were independent predictors of compliance to the NSTGs. The main behaviours associated with antibiotic prescribing were patient influences, clinical state, and access to guidelines. Conclusions: Compliance with NSTGs is suboptimal. Prescribing of combination antibiotics, penicillins and diagnosis of oral dental, genitourinary and ear, nose and throat infections were important predictors for NSTG compliance. There is a need to implement antibiotic indicators and stewardship programmes, and ensure access to NSTGs, to improve future antibiotic prescribing in Namibia.


Expert Review of Anti-infective Therapy | 2016

Effect of changing from first- to second- line antiretroviral therapy on renal function: a retrospective study based on data from a single health facility in Namibia

Francis Kalemeera; Christofina Mbango; Mwangana Mubita; Esther Naikaku; Razia Gaida; Brian Godman

ABSTRACT Background: Tenofovir disoproxil fumarate (TDF) and lopinavir/ritonavir (LPV/r) can cause renal impairment with this combination co-administered during second-line combination antiretroviral therapy (cART) potentially associated with greater risk of nephrotoxicity. As a result, the aim of this study is to assess effects of second-line cART on renal function. Methods: Retrospective longitudinal study in patients receiving cART. Results: 71 patients received TDF, zidovudine or stavudine, each combined with 3TC/NVP or 3TC/EFV. Before second-line cART, 46.5% had abnormal kidney function. First-line cART had no relationship with calculated creatinine clearance (CrCl). During second-line cART, more males than females had abnormal renal function and more females experienced increases in CrCl. Calculated CrCl during second-line cART related strongly with CrCl during first-line cART. Time spent on cART weak had a week relationship with CrCl. Conclusion: Patients on first-line cART for several years without renal impairment may experience new onset impairment during second line cART. Patients with pre-existing renal impairment just before switching to second-line cART may experience a further decline.


Archive | 2017

Initiatives across countries to reduce antibiotic utilization and resistance patterns: impact and implications

Brian Godman; Joseph Fadare; Dan Kibuule; Lyna Irawati; Mwangana Mubita; Olayinka Ogunleye; Margaret Oluka; Bene D Anand Paramadhas; Juliana de Oliveira Costa; Lívia Lovato Pires de Lemos; Augusto Afonso Guerra Júnior; Alian A. Alrasheedy; Mohamed Azimi Hassali; Fahad Saleem; Thu Huong; Ilse Truter

Introduction: Greater accessibility to antibiotics has resulted in their excessive use, leading to increasing antimicrobial resistance (AMR) and strains on healthcare systems, with only a limited number of patients in ambulatory care treated according to guidelines. High rates of AMR are now seen across countries and continents, resulting in AMR becoming one of the most critical issues facing healthcare systems. It is estimated that AMR could potentially cause over 10 million deaths per year by 2050 unless addressed, resulting in appreciable economic consequences. There are also concerns with under-treatment especially if patients are forced to fund more expensive antibiotics as a result of AMR to first-line antibiotics and do not have available funds. Overprescribing of antibiotics is not helped by patient pressure even when physicians are aware of the issues. There is also extensive dispensing of antibiotics without a prescription, although this is now being addressed in some countries. Aim: Review interventions that have been instigated across continents and countries to reduce inappropriate antibiotic prescribing and dispensing, and associated AMR, to provide future guidance. Method: Narrative case history approach. Findings: A number of successful activities have been instigated to reduce inappropriate prescribing and dispensing of antibiotics across sectors. These include the instigation of quality indicators, suggested activities of pharmacists as well as single and multiple interventions among all key stakeholder groups. Multiple interlinking strategies are typically needed to enhance appropriate antibiotic prescribing and dispensing. The impact of ongoing activities need to be continually analysed to provide future direction if AMR rates, and their impact on subsequent morbidity, mortality and costs, are to be reduced.


Archive | 2019

Teaching Pharmaceutical Care to Pharmacists and Other Health Professionals

Martin Henman; Dan Kibuule; Mwangana Mubita

Educating pharmacists about pharmaceutical care begins with re-orientating them to the provision of care rather than the supply of a medicine. Then the pharmacist’s knowledge and understanding must be developed and tailored to the steps of providing care; assessing the problem, identifying and prioritizing problems, planning the interventions, implementing changes, monitoring, and follow-up. In order to do this, it is necessary to have integrated academic and work-based learning with appropriately qualified and experienced professionals who take on the roles of facilitators, supervisors, mentors, and coaches as necessary. Suitable methods of assessment help the learner to gage their progression.


Journal of Ancient Diseases & Preventive Remedies | 2017

The Potential Effect of Using the Cockcroft-Gault Method on Tenofovir-Associated Renal Impairment Reports and on Clinical Decisions Regarding Tenofovir Use in Individual Patients: Implications for the Future

Francis Kalemeera; Marike Cockeran; Mwangana Mubita; Dan Kibuule; Ester Naikaku; Amos Massele; Brian Godman

Introduction: In Namibia, the Cockcroft-Gault (C-G) method is recommended for monitoring renal function in HIV patients receiving Tenofovir Disoproxil Fumarate (TDF)-containing Combination Antiretroviral Therapy (cART). However, there are concerns with the potential over-reporting of TDF-associated renal impairment. Methods: Retrospective study comparing the renal function of patients receiving 2nd line cART with either C-G or Chronic Kidney Disease-Epidemiology (CKD-EPI) methods. Results: 71 patients were included. The majority (62%) received TDF-containing 1st line ART. All received 2ndline cART containing TDF/Lamivudine (3TC)/Zidovudine (AZT) and LPV/r. Before switching to 2nd-line cART, 40.8% and 8.5% had abnormal eGFR according to C-G and CKD-EPI methods respectively. During 2nd-line cART, 47.9% and 7% of patients had abnormal eGFR by C-G and CKD-EPI methods, respectively, and 4.1% and 2.8% respectively experienced a decline in eGFR. There was a significant lack of agreement between the two methods. Conclusion: The C-G method has the potential to report more cases of TDF-associated renal impairment. Consequently, national guidelines in Namibia and other pertinent countries should be reviewed if this is the recommended method for monitoring renal function.


Cardiovascular Drugs and Therapy | 2017

Assessing adherence to Antihypertensive therapy in primary health care in Namibia: findings and implications

M.N Nashilongo; B Singu; Francis Kalemeera; Mwangana Mubita; Ester Naikaku; Amanj Baker; Alessandra Ferrario; Brian Godman; Loice Achieng; Dan Kibuule


Pharmacy Education | 2018

Short report: Piloting a new pharmacy internship support programme in Namibia

Timothy Rennie; Nardia Coetzee; Christian J. Hunter; Lauren J. Jonkman; Frances Kalemeera; Dan Kibuule; Jennie Lates; Mwangana Mubita; Vulika Nangombe; Helen Rowlandson; Nicola Rudall


International Journal of Clinical Pharmacy | 2018

Monitoring of gentamicin serum concentrations in obstetrics and gynaecology patients in Namibia

Bonifasius Singu; Mwangana Mubita; Moses M. Thikukutu; Josef K. Mufenda; Shonag B. McKenzie; Roger K. Verbeeck


Pharmacy Education | 2016

Current and former students' views on two different methods of classroom-based teaching in pharmaceutical care: University of Namibia

Francis Kalemeera; Ester Naikaku; Mwangana Mubita; Dan Kibuule

Collaboration


Dive into the Mwangana Mubita's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

B Singu

University of Namibia

View shared research outputs
Researchain Logo
Decentralizing Knowledge